CERo Therapeutics Holdings Inc (CERO)
1.11
-0.02
(-1.77%)
USD |
NASDAQ |
May 17, 16:00
1.11
0.00 (0.00%)
After-Hours: 20:00
CERo Therapeutics Holdings Free Cash Flow (Quarterly)
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2023 | -1.437M |
| Date | Value |
|---|---|
| March 31, 2022 | -4.204M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-4.204M
Minimum
Mar 2022
-1.437M
Maximum
Mar 2023
-2.820M
Average
-2.820M
Median
Free Cash Flow (Quarterly) Benchmarks
| Ainos Inc | -1.499M |
| Ventyx Biosciences Inc | -47.80M |
| Mind Medicine Inc | -16.60M |
| Avid Bioservices Inc | -0.801M |
| Creative Medical Technology Holdings Inc | -0.8969M |